Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Fraguas

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
European Child & Adolescent Psychiatry|March 2, 2015
Functional deterioration from the premorbid period to 2 years after the first episode of psychosis in early-onset psychosisÁngel Del Rey-Mejías, David Fraguas, Covadonga M Díaz-Caneja, et al.
Schizophrenia (Heidelberg, Germany)|March 12, 2022
Cortical thinning over two years after first-episode psychosis depends on age of onsetLaura Pina-Camacho, Kenia Martinez, Covadonga M Diaz-Caneja, et al.
Molecular Autism|March 5, 2022
Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysisSpyridon Siafis, Oğulcan Çıray, Hui Wu, et al.
Schizophrenia Research|February 1, 2020
Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs studyClemente García-Rizo, Miquel Bioque, Gisela Mezquida, et al.
BMC Psychiatry|February 16, 2011
Reduced antioxidant defense in early onset first-episode psychosis: a case-control studyJuan Antonio Micó, Maria Olga Rojas-Corrales, Juan Gibert-Rahola, et al.
Revista De Psiquiatria Y Salud Mental|December 3, 2014
Pharmacogenetic study of second-generation antipsychotic long-term treatment metabolic side effects (the SLiM Study): rationale, objectives, design and sample descriptionLaura Pina-Camacho, Covadonga M Díaz-Caneja, Pilar A Saiz, et al.
Psychological Medicine|September 9, 2020
The impact of cognitive reserve, cognition and clinical symptoms on psychosocial functioning in first-episode psychosesSilvia Amoretti, Adriane R Rosa, Gisela Mezquida, et al.
Schizophrenia Research|July 19, 2014
A longitudinal study on the relationship between duration of untreated psychosis and executive function in early-onset first-episode psychosisDavid Fraguas, Jessica Merchán-Naranjo, Ángel del Rey-Mejías, et al.
Revista De Psiquiatria Y Salud Mental|July 15, 2022
Prefrontal abnormalities, executive dysfunction and symptoms severity are modulated by COMT Val<sub>158</sub>Met polymorphism in first episode psychosisElisa Rodríguez-Toscano, Kenia Martínez, David Fraguas, et al.
Expert Opinion on Drug Safety|February 18, 2016
Switching long acting antipsychotic medications to aripiprazole long acting once-a-month: expert consensus by a panel of Italian and Spanish psychiatristsAndrea Fagiolini, Emilia Alfonsi, Giovanni Amodeo, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
European Child & Adolescent Psychiatry|March 2, 2015
Functional deterioration from the premorbid period to 2 years after the first episode of psychosis in early-onset psychosisÁngel Del Rey-Mejías, David Fraguas, Covadonga M Díaz-Caneja, et al.
Schizophrenia (Heidelberg, Germany)|March 12, 2022
Cortical thinning over two years after first-episode psychosis depends on age of onsetLaura Pina-Camacho, Kenia Martinez, Covadonga M Diaz-Caneja, et al.
Molecular Autism|March 5, 2022
Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysisSpyridon Siafis, Oğulcan Çıray, Hui Wu, et al.
Schizophrenia Research|February 1, 2020
Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs studyClemente García-Rizo, Miquel Bioque, Gisela Mezquida, et al.
BMC Psychiatry|February 16, 2011
Reduced antioxidant defense in early onset first-episode psychosis: a case-control studyJuan Antonio Micó, Maria Olga Rojas-Corrales, Juan Gibert-Rahola, et al.
Revista De Psiquiatria Y Salud Mental|December 3, 2014
Pharmacogenetic study of second-generation antipsychotic long-term treatment metabolic side effects (the SLiM Study): rationale, objectives, design and sample descriptionLaura Pina-Camacho, Covadonga M Díaz-Caneja, Pilar A Saiz, et al.
Psychological Medicine|September 9, 2020
The impact of cognitive reserve, cognition and clinical symptoms on psychosocial functioning in first-episode psychosesSilvia Amoretti, Adriane R Rosa, Gisela Mezquida, et al.
Schizophrenia Research|July 19, 2014
A longitudinal study on the relationship between duration of untreated psychosis and executive function in early-onset first-episode psychosisDavid Fraguas, Jessica Merchán-Naranjo, Ángel del Rey-Mejías, et al.
Revista De Psiquiatria Y Salud Mental|July 15, 2022
Prefrontal abnormalities, executive dysfunction and symptoms severity are modulated by COMT Val<sub>158</sub>Met polymorphism in first episode psychosisElisa Rodríguez-Toscano, Kenia Martínez, David Fraguas, et al.
Expert Opinion on Drug Safety|February 18, 2016
Switching long acting antipsychotic medications to aripiprazole long acting once-a-month: expert consensus by a panel of Italian and Spanish psychiatristsAndrea Fagiolini, Emilia Alfonsi, Giovanni Amodeo, et al.
Pageof 8